Drug intelligence / Profile preview

Formula 7 The Solution

Development stage: Unknown
Lead developer: Tetra Corporation
Modality: Small Molecules
Administration: Topical

Overview

Formula 7 The Solution is a human over-the-counter topical antifungal solution developed and manufactured by Tetra. It contains tolnaftate 1% as its sole active ingredient in a patented oil-in-water microemulsion delivery system. It is labeled for treatment of most athlete's foot and ringworm and for prevention of recurrence of athlete's foot with daily use. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18619649-7f79-4b6e-8b7c-69d70365d557))

Brand names: Formula 7 The SolutionFormula7 The SolutionFormula-7 The Solution

Targets

SQLE (Squalene monooxygenase)

Beyond the preview

Go deeper on Formula 7 The Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formula 7 The Solution.

Explore the full profile